146 related articles for article (PubMed ID: 16707922)
1. Contortrostatin, a snake venom disintegrin with anti-angiogenic and anti-tumor activity.
Swenson S; Costa F; Ernst W; Fujii G; Markland FS
Pathophysiol Haemost Thromb; 2005; 34(4-5):169-76. PubMed ID: 16707922
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel recombinant disintegrin, contortrostatin, as an effective anti-tumor and anti-angiogenic agent.
Minea R; Swenson S; Costa F; Chen TC; Markland FS
Pathophysiol Haemost Thromb; 2005; 34(4-5):177-83. PubMed ID: 16707923
[TBL] [Abstract][Full Text] [Related]
3. Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression.
Swenson S; Costa F; Minea R; Sherwin RP; Ernst W; Fujii G; Yang D; Markland FS
Mol Cancer Ther; 2004 Apr; 3(4):499-511. PubMed ID: 15078994
[TBL] [Abstract][Full Text] [Related]
4. A novel snake venom disintegrin that inhibits human ovarian cancer dissemination and angiogenesis in an orthotopic nude mouse model.
Markland FS; Shieh K; Zhou Q; Golubkov V; Sherwin RP; Richters V; Sposto R
Haemostasis; 2001; 31(3-6):183-91. PubMed ID: 11910184
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and functional expression of contortrostatin, a homodimeric disintegrin from southern copperhead snake venom.
Zhou Q; Hu P; Ritter MR; Swenson SD; Argounova S; Epstein AL; Markland FS
Arch Biochem Biophys; 2000 Mar; 375(2):278-88. PubMed ID: 10700384
[TBL] [Abstract][Full Text] [Related]
6. Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: A review.
Schönthal AH; Swenson SD; Chen TC; Markland FS
Biochem Pharmacol; 2020 Nov; 181():114149. PubMed ID: 32663453
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenic activity of contortrostatin, a disintegrin from Agkistrodon contortrix contortrix snake venom.
Golubkov V; Hawes D; Markland FS
Angiogenesis; 2003; 6(3):213-24. PubMed ID: 15041797
[TBL] [Abstract][Full Text] [Related]
8. Contortrostatin, a snake venom disintegrin, inhibits beta 1 integrin-mediated human metastatic melanoma cell adhesion and blocks experimental metastasis.
Trikha M; De Clerck YA; Markland FS
Cancer Res; 1994 Sep; 54(18):4993-8. PubMed ID: 7520832
[TBL] [Abstract][Full Text] [Related]
9. Blocking αvβ3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells.
Montenegro CF; Salla-Pontes CL; Ribeiro JU; Machado AZ; Ramos RF; Figueiredo CC; Morandi V; Selistre-de-Araujo HS
Biochimie; 2012 Aug; 94(8):1812-20. PubMed ID: 22561350
[TBL] [Abstract][Full Text] [Related]
10. Contortrostatin, a snake venom disintegrin, induces alphavbeta3-mediated tyrosine phosphorylation of CAS and FAK in tumor cells.
Ritter MR; Zhou Q; Markland FS
J Cell Biochem; 2000 Jul; 79(1):28-37. PubMed ID: 10906753
[TBL] [Abstract][Full Text] [Related]
11. Contortrostatin, a homodimeric disintegrin, binds to integrin alphavbeta5.
Zhou Q; Nakada MT; Brooks PC; Swenson SD; Ritter MR; Argounova S; Arnold C; Markland FS
Biochem Biophys Res Commun; 2000 Jan; 267(1):350-5. PubMed ID: 10623623
[TBL] [Abstract][Full Text] [Related]
12. The disintegrin contortrostatin in combination with docetaxel is a potent inhibitor of prostate cancer in vitro and in vivo.
Lin E; Wang Q; Swenson S; Jadvar H; Groshen S; Ye W; Markland FS; Pinski J
Prostate; 2010 Sep; 70(12):1359-70. PubMed ID: 20623636
[TBL] [Abstract][Full Text] [Related]
13. Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits breast cancer progression.
Zhou Q; Sherwin RP; Parrish C; Richters V; Groshen SG; Tsao-Wei D; Markland FS
Breast Cancer Res Treat; 2000 Jun; 61(3):249-60. PubMed ID: 10966001
[TBL] [Abstract][Full Text] [Related]
14. Contortrostatin, a homodimeric disintegrin isolated from snake venom inhibits herpes simplex virus entry and cell fusion.
Hubbard S; Choudhary S; Maus E; Shukla D; Swenson S; Markland FS; Tiwari V
Antivir Ther; 2012; 17(7):1319-26. PubMed ID: 22875654
[TBL] [Abstract][Full Text] [Related]
15. Contortrostatin, a homodimeric snake venom disintegrin, is a potent inhibitor of osteoclast attachment.
Mercer B; Markland F; Minkin C
J Bone Miner Res; 1998 Mar; 13(3):409-14. PubMed ID: 9525341
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumor formation by snake venom disintegrin.
Yang RS; Tang CH; Chuang WJ; Huang TH; Peng HC; Huang TF; Fu WM
Toxicon; 2005 Apr; 45(5):661-9. PubMed ID: 15777962
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenesis and RGD-containing snake venom disintegrins.
Swenson S; Ramu S; Markland FS
Curr Pharm Des; 2007; 13(28):2860-71. PubMed ID: 17979731
[TBL] [Abstract][Full Text] [Related]
18. [Snake venom disintegrins: classification and therapeutic potential].
Kallech-Ziri O; Luis J; El Ayeb M; Marrakchi N
Arch Inst Pasteur Tunis; 2007; 84(1-4):29-37. PubMed ID: 19388581
[TBL] [Abstract][Full Text] [Related]
19. From Discovery of Snake Venom Disintegrins to A Safer Therapeutic Antithrombotic Agent.
Kuo YJ; Chung CH; Huang TF
Toxins (Basel); 2019 Jun; 11(7):. PubMed ID: 31247995
[TBL] [Abstract][Full Text] [Related]
20. Antitumoral Potential of Lansbermin-I, a Novel Disintegrin from Porthidium lansbergii lansbergii Venom on Breast Cancer Cells.
Montealegre-Sánchez L; Gimenes SNC; Lopes DS; Teixeira SC; Solano-Redondo L; de Melo Rodrigues V; Jiménez-Charris E
Curr Top Med Chem; 2019; 19(22):2069-2078. PubMed ID: 31385773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]